Literature DB >> 28606968

Dendritic cells should not be overlooked when studying the effect of IL-38 administration in arthritis.

Kuo Jiang1, Yunshan Guo1, Lin Xiao1, Wenjie Pan1, Jianbing Ma1.   

Abstract

Entities:  

Keywords:  Arthritis; Cytokines; Inflammation; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2017        PMID： 28606968     DOI： 10.1136/annrheumdis-2017-211780

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

Review 1.  Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study.

Authors:  Abdolreza Esmaeilzadeh; Nazila Bahmaie; Elham Nouri; Mohammad Javad Hajkazemi; Maryam Zareh Rafie
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

Review 2.  IL-38: A New Player in Inflammatory Autoimmune Disorders.

Authors:  Lihui Xie; Zhaohao Huang; He Li; Xiuxing Liu; Songguo Zheng; Wenru Su
Journal:  Biomolecules       Date:  2019-08-05

3.  Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Authors:  Yun Ge; Man Huang; Yao Wu; Ning Dong; Yong-Ming Yao
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.